November 14, 2024 04:01 PM Eastern Standard Time LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Adagio Medical Holdings, Inc. (Nasdaq: ADGM; the “Company” or “Adagio”), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, today announced, today provided business updates for third quarter ended September 30, 2024. Recent Business Highlights: Reported […]
Other News
Acutus Medical Reports Third Quarter and Year-To-Date 2024 Financial Results
CARLSBAD, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the third quarter and year-to-date of 2024.
FDA Grants De Novo Authorization to OMRON Healthcare for New Blood Pressure Monitors with AI-Powered AFib Detection Feature
Advancing its Going for Zero mission, OMRON innovation makes AFib screening an integral part of the brand’s routine home blood pressure monitoring experience HOFFMAN ESTATES, Ill., Nov. 14, 2024 /PRNewswire/ — In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare…
Mach7 Technologies Sets the Stage for the Future of Patient Imaging at RSNA 2024
Highlighted by the launch of UnityVue, a next-generation radiology reading solution, Mach7 will showcase Enterprise Imaging that connects clinicians and patients to enable exceptional care. SOUTH BURLINGTON, Vt., Nov. 14, 2024 /PRNewswire/ — Mach7 Technologies, a company specializing in…
HUYABIO Validates Protective Mechanism for Antiarrhythmic Drug HBI-3000 in AF Patients, Paving the Way for a New Era in Atrial Fibrillation Treatment
HBI-3000 Aims to Fill Critical Gaps in Atrial Fibrillation Care; Key Data to be Presented at the American Heart Association Annual Meeting SAN DIEGO, Nov. 14, 2024 /PRNewswire/ — HUYABIO International today announced the presentation of new patient data for HBI-3000, an antiarrhythmic…
Post-Hoc Analysis Demonstrating Sotagliflozin Benefits Across Broad Spectrum of Heart Failure Patient Populations is Among Four Lexicon-Supported Presentations at the American Heart Association’s (AHA) Sessions 2024 in Chicago
Study results add to the growing body of evidence differentiating sotagliflozin within SGLT inhibitor class Study results add to the growing body of evidence differentiating sotagliflozin within SGLT inhibitor class
At RSNA 2024, Agfa Radiology Solutions’ in-booth presentations empower X-ray experts with insights and innovations
Visitors to Agfa’s booth can discover a series of concise, expert-led sessions covering crucial topics in radiology and diagnostic imaging MORTSEL, Belgium, Nov. 13, 2024 /PRNewswire/ — Concise, impactful presentations cover challenging topics ranging from notifications of urgent…
RADPAIR Named “Best New Radiology Vendor 2024” at AuntMinnie.com’s Minnies Awards
KNOXVILLE, Tenn., Nov. 13, 2024 /PRNewswire/ — RADPAIR, a Knoxville-based radiology tech startup founded by radiologist and CEO Dr. Avez Rizvi, has been awarded “Best New Radiology Vendor 2024” by AuntMinnie.com. This recognition highlights RADPAIR’s AI-driven platform, designed to…
HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement
Southlake, TX, Nov. 13, 2024 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that the Centers for Medicare & Medicaid Services (CMS) has included AI-ECG technology in the 2025 Hospital Outpatient Prospective Payment System (OPPS) final rule under assignment APC 5734. This approval would allow outpatient settings to receive reimbursement for HeartSciences’ MyoVista® wavECGTM algorithm and MyoVista® InsightsTM low ejection fraction algorithm, upon FDA clearance. The payment rate is expected to be $125.
Revolutionizing Heart Health: Frontier X Plus Gains FDA Clearance
NEW YORK, Nov. 13, 2024 /PRNewswire/ — Fourth Frontier, a medical technology company based out of New York and Bangalore, announced the 510(k) clearance of the Frontier X Plus from the U.S. FDA. The Frontier X Plus is an innovative single-lead, continuous ECG monitor that is worn around…



